Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diffusion-weighted MRI--a new parameter for advanced rectal carcinoma?].

P A Hein1, C Kremser, W Judmaier

  • 1Universitätsklinik für Strahlentherapie, Leopold-Franzens Universität Innsbruck, Austria. Patrick.A.Hein@hitchcock.org

Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|March 14, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proton-Based Re-Irradiation of Locally Recurrent Pediatric Brain Tumors in Close Proximity to the Brainstem.

International journal of particle therapy·2026
Same author

MRI analysis of simple and aneurysmal bone cysts in the proximal humerus: what actually matters in clinical routine.

Skeletal radiology·2021
Same author

Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer-a valid option for cisplatin-unfit patients?

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2021
Same author

Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2020
Same author

[Scientific assessment and regulatory approval of radiological screening examinations in Germany].

Der Radiologe·2020
Same author

Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Histochemistry and cell biology·2020

Apparent diffusion coefficient (ADC) measured by MRI can predict rectal cancer treatment response. Lower ADC values indicate better outcomes after chemoradiation, aiding in therapy planning.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Rectal cancer treatment response prediction is crucial for personalized therapy.
  • Neoadjuvant chemoradiation is a standard treatment for locally advanced rectal cancer.
  • Non-invasive imaging biomarkers are needed to assess treatment efficacy.

Purpose of the Study:

  • To determine if apparent diffusion coefficient (ADC) measured via MRI can predict treatment outcomes in rectal cancer patients.
  • To evaluate the correlation between pre-treatment ADC values and histopathologic response to neoadjuvant chemoradiation.

Main Methods:

  • 16 patients with cT3 rectal carcinoma underwent MRI before neoadjuvant chemoradiation.
  • Diffusion-weighted (SE-EPI) and contrast-enhanced T1-weighted (SE) images were acquired at 1.5T.

Related Experiment Videos

  • Mean ADC of the tumor was calculated and correlated with postsurgical histopathologic staging.

    • Main Results:

    • Tumor down-staging (pT0-2) was observed in 9 patients (responders), while 7 patients (non-responders) showed no down-staging (pT3).
    • The mean ADC was significantly lower in responders (0.476 ± 0.114 x 10⁻³ mm²/s) compared to non-responders (0.703 ± 0.085 x 10⁻³ mm²/s).
    • The difference in mean ADC between responders and non-responders was statistically significant (p = 0.001).

    Conclusions:

    • Mean ADC derived from MRI shows potential as a quantitative biomarker for predicting treatment response.
    • ADC measurements could aid in tailoring neoadjuvant chemoradiation strategies for rectal cancer patients.
    • This quantitative imaging parameter may improve therapeutic outcome prediction in rectal cancer management.